NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of USANA Health Sciences, Inc. (NYSE: USNA) resulting from allegations that USANA Health may have issued materially misleading business information to the investing public.
On February 7, 2017, USANA Health disclosed during aftermarket hours that “[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd….focus[ing] on the compliance with the Foreign Corrupt Practices Act… and certain conduct and policies at BabyCare, including BabyCare’s expense reimbursement policies.” USANA Health advised investors that it had retained outside counsel to conduct the investigation and had notified both the Securities and Exchange Commission and the Department of Justice of the pending investigation. On this news, shares of USANA Health fell sharply during intraday trading on February 8, 2017.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by USANA Health investors. If you purchased shares of USANA Health on or before February 7, 2017 please visit the firm’s website at http://www.rosenlegal.com/cases-1053.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.